In human GBM, BMP4 signaling downstream target ID1 was identified as a biomarker to distinguish a subpopulation of quiescent GSCs together with the opposite expression pattern of p21 in transforming growth factor-β (TGF-β) signaling (Sachdeva et al. 2019). The gene discussed is BMP4; the disease is glioblastoma.